drugset / Trial / NCT02464059

Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD

NCT02464059

NaSingle-groupOpen-labelBasic science

Summary

This proposal will evaluate a potential mechanism of increased risk of lung function impairment, cathelicidin levels, as well as determine if vitamin D replacement can alter this pathway. This study will improve the understanding of factors which can lead to chronic lung disease. If effective, this application would also provide the justification to study vitamin D as a therapy to improve lung health.

Timeline

Start
2015-11-10
Primary completion
2020-04-15
Completion
2020-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 50000 iu Oral